COVID-19’s Impact on the Leading Causes of Death in the US
Drug Topics
AUGUST 13, 2024
Experts analyzed data from the National Center for Health Statistics on the leading causes of death in the US from the last 5 years.
Tue.Aug 13, 2024
201 
STAT+: Meet the billionaire media mogul who’s taking on the food industry
STAT
AUGUST 13, 2024
WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came to him after visiting George Clooney in Lake Como. He’s recruited Morgan Freeman, who is “obviously” a friend. He personally lobbied Arnold Schwarzenegger and current California Gov. Gavin Newsom to support food makers’ nightmare scenario — a first-in-the-nation law banning certain food additives in the state, which was signed into law last year.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
First FDA-Approved Digital Therapeutic to Treat Depression Now Available in App Stores
Drug Topics
AUGUST 13, 2024
Rejoyn, developed by Otsuka Pharmaceutical and Click Therapeutics, is only accessible with a prescription from a health care provider.
STAT+: Grail announces layoffs as it looks to push forward blood-based cancer detection test
STAT
AUGUST 13, 2024
Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save cash and concentrate resources on developing a blood-based test to spot early signs of dozens of cancers. The cuts will affect 30% of the biotech’s current and planned hires. Grail spokesperson Kristen Davis told STAT in an email that around 350 existing positions and 150 open roles have been eliminated.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Approves First Monoclonal Antibody to Treat Prurigo Nodularis
Drug Topics
AUGUST 13, 2024
Two phase 3 trials evaluating nemolizumab found that 41% of patients treated with the therapy achieved at least a 4-point reduction in itch intensity at week 16.
STAT+: Why U.S. health care cybersecurity laws are better at protecting a corpse’s privacy than patients’ lives
STAT
AUGUST 13, 2024
Two days into a cyberattack on his hospital system, Nate Couture reached the end of his cyber incident plan. “We make these incident response plans and we feel great about them,” Couture, the University of Vermont Health Network chief information security officer, told other heath care cyber professionals at a recent conference. “At the end of them, they have a box that usually says something like, ‘And then IT recovers the systems.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Illumina lays out plan to boost growth by helping scientists interpret sequencing data
STAT
AUGUST 13, 2024
SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left investors and the genomics community with a pressing question: What kind of company is Illumina going to be going forward? CEO Jacob Thaysen on Tuesday made clear that the sequencing firm, which controls about 80% of the current DNA-sequencer market, is essentially returning to its traditional role of creating instruments for researchers in academia, the biopharma industry, and health care
Steward Health Care agrees to sell physician group to private equity affiliate in $245M deal
Fierce Healthcare
AUGUST 13, 2024
Steward Health Care has agreed to sell its physicians network, Stewardship Health, to Rural Healthcare Group, which is owned by a private equity group. | Steward Health Care has agreed to sell its doctors network, Stewardship Health, to Rural Healthcare Group, which is owned by a private equity group.
Atai advances oral psychedelic in depression
STAT
AUGUST 13, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, the FDA’s recent rejection of an MDMA therapy hasn’t seemed to deter some other companies from moving ahead with psychedelics studies. We discuss that, and also some big policy developments that are coming this week.
People need to know how to use AI now
pharmaphorum
AUGUST 13, 2024
With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Opinion: Aspirin after a broken bone: health equity in a $5 bottle
STAT
AUGUST 13, 2024
There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New England Journal of Medicine published our findings in January 2023 that aspirin was as effective at preventing life-threatening blood clots after surgery as was a far more expensive and more painful injectable blood thinner.
Industry Voices—Empowering community health workers to improve value-based care
Fierce Healthcare
AUGUST 13, 2024
In places like rural El Paso, Texas, community health workers (CHWs) help thousands of underserved individuals obtain the food, housing and medical services they need to survive. | While there’s no silver bullet to save VBC, community-based health workers are best positioned to protect it.
STAT+: Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug
STAT
AUGUST 13, 2024
Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental drug for a common skin disorder succeeded in a late-stage clinical trial. That’s the kind of news that’s usually accompanied by plans to apply for regulatory approval to market a new therapy. But the results didn’t show a clear edge over competing products on the market or in development.
Advancing precision medicine: How real-world evidence platforms translate data into action
pharmaphorum
AUGUST 13, 2024
Learn how real-world evidence platforms use real-world data (RWD) to advance precision medicine, bridging the gap between clinical trials and real-world patient outcomes.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Otsuka prices depression digital therapeutic to make it widely accessible, says it’ll lose money
STAT
AUGUST 13, 2024
Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that treats the symptoms of major depressive disorder. And it’s hitting the market at a low price that Otsuka hopes will entice many people to give it a try. Otsuka will make the 6-week treatment available to patients through a prescription from their existing provider or through the treatment’s website where they can connect with a clinician from Wheel Health who can prescri
Remembering Paul Bannister, dear friend and finance manager
pharmaphorum
AUGUST 13, 2024
Our longtime Finance Director Paul Bannister was a part of the fabric of pharmaphorum almost from the beginning and an integral part of keeping the publication running. And, most importantly, he was the soul of the place and a friend to all.
The politics of mifepristone in the 2024 election
STAT
AUGUST 13, 2024
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Hello and happy Tuesday, D.C. Diagnosis readers! I’m sad that the Olympics are already over, and it seems like the athletes receiving free health care must be too.
Vivid Health brings generative AI into home healthcare, hospital-at-home services
Fierce Healthcare
AUGUST 13, 2024
Vivid Health is launching into the at-home care market to help clinical staff more efficiently fill out required, but time-consuming, assessment forms, reduce staff burnout and increase c | Digital health startup Vivid Health is a multispecialty care management platform that leverages generative AI to create patient care plans. The solution is particularly well suited for the home health sector, which struggles with capacity and burnout.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch
Fierce Pharma
AUGUST 13, 2024
Despite winning an FDA approval in 2023 and gaining clarity in May on the regulatory path forward for its Type 1 diabetes prospect sotagliflozin, Lexicon Pharmaceuticals hasn’t had an easy go of it | As part of a restructuring initiative, Lexicon Pharmaceuticals will lay off more than 75 staffers, or approximately 50% of its current field force, by the end of September.
54% of Medicare eligibles enrolled in MA for 2024: KFF
Fierce Healthcare
AUGUST 13, 2024
Fifty-four percent of Medicare beneficiaries are enrolled in a private Medicare Advantage plan, and in seven states that figure tops 60%, according to a new report from KFF. | Fifty-four percent of Medicare beneficiaries are enrolled in a private Medicare Advantage plan, and in seven states that figure tops 60%, according to a new report from KFF.
4 foods to avoid while on Saxenda
The Checkup by Singlecare
AUGUST 13, 2024
Read any articles on the latest strategies for losing weight or ask any friends who have been trying to shed a few pounds, and you’ll likely notice a trend: The class of weight-management drugs known as glucagon-like peptide-1 (GLP-1) agonists are having a moment. Among these is the brand-name drug Saxenda (liraglutide). This prescription medication is FDA approved to regulate appetite and promote weight loss in adults with a body mass index (BMI) of 30 or higher and those with a BMI over 27 who
China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome
Pharmafile
AUGUST 13, 2024
The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine for the first time in newly diagnosed patients with higher-risk myelodysplastic syndrome (MDS). The post China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome appeared first on Pharmafile.
What Do You Do When You Hit a Weight Loss Plateau?
Compounding Pharmacy of America
AUGUST 13, 2024
Stuck in a weight loss plateau? Learn effective tips, strategies and supplements to help break through and continue your fitness journey. The post What Do You Do When You Hit a Weight Loss Plateau? appeared first on The Compounding Pharmacy of America.
Does Ozempic cause headaches?
The Checkup by Singlecare
AUGUST 13, 2024
For people with Type 2 diabetes, the injectable drug Ozempic (semaglutide) can lower blood sugar, reduce the risk of heart disease, and help with weight loss. It’s a glucagon-like peptide 1 (GLP-1) receptor agonist that works several different ways to manage Type 2 diabetes. Although Ozempic doesn’t have any direct effect on the neurological system, some people have reported headaches while taking the drug.
How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies
Outsourcing Pharma
AUGUST 13, 2024
Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology industry.
Dengue Vaccine TAK-003 Confirmed to be Safe, Effective
Drug Topics
AUGUST 13, 2024
TAK-003 could be a powerful combatant against the increasing global threat of dengue virus.
CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US
Fierce Pharma
AUGUST 13, 2024
CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US fkansteiner Tue, 08/13/2024 - 13:42
Revolutionizing partner evaluations in pharma outsourcing: expert insights
Outsourcing Pharma
AUGUST 13, 2024
In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation.
Novartis loses bid to thwart launch of MSN's Entresto generic—for now
Fierce Pharma
AUGUST 13, 2024
After seeking to block the launch of MSN Pharmaceuticals’ recently approved Entresto generic, Novartis has hit a snag in its multiyear crusade to thwart copycats of its top-selling heart failure dr | After seeking to block the launch of MSN Pharmaceuticals’ recently approved Entresto generic, Novartis has hit a snag in its multiyear crusade to thwart copycats of its top-selling heart failure drug.
Morning Rounds: The billionaire who wants you angry about the food supply
STAT
AUGUST 13, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. We’ve got some nice awards news this morning. Yesterday, my colleague and friend Jason Mast won the the 2024 Evert Clark/Seth Payne Award , for his reporting at the intersection of medical science, business, and human lives. I asked Jason if there was a STAT story he was most proud of and he shared this heart-wrenching one from last summer when the first gene therapy was approved fo
Investor activism resurfaces at Aurinia after CEO’s board role, exec pay lost majority support
Fierce Pharma
AUGUST 13, 2024
A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals. | A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals.
#WeCount: In Q1 2024, women in the US received more abortions than ever, bolstered by telehealth
Fierce Healthcare
AUGUST 13, 2024
More people are receiving abortion care per month in the first quarter of 2024 than before the Supreme Court struck down the national right to abortion in the 2022 Dobbs v. | #WeCount is a national abortion reporting effort that began in April 2022, just before the Supreme Court struck down the national right to abortion. Even though 14 states have near-total abortion bans, the number of abortions rose year-over-year from 2023—and hit an all-time high.
FDA approval of needle-free spray, a major breakthrough in anaphylaxis treatment
Outsourcing Pharma
AUGUST 13, 2024
Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA) has approved neffy, a 2 mg epinephrine nasal spray developed by ARS Pharmaceuticals, Inc.
Let's personalize your content